Melinta Therapeutics
Manufacturing · New Jersey, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
389 Interpace Pkwy Ste 450, Parsippany, ...Phone Number
(908) 617-1309Website
www.melinta.comRevenue
$96.4 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Melinta Therapeutics
Founded in 2000, Melinta Therapeutics biopharmaceutical firm that focuses on the design and development of novel broad-spectrum antibiotics for the treatment of antibiotic-resistant infections in hospital and community settings.Explore more
Melinta Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Melinta Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Melinta Therapeutics recently announced quarterly report
Check out if Melinta Therapeutics is spiking on competitors!
Product Launch: Get notified when Melinta Therapeutics launches new products
Check if Melinta Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Melinta Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Melinta Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Melinta Therapeutics
Funding: Get notified immidiatlly once Melinta Therapeutics has new funding data
Recommended Actions
Reach out to Masked Content who joined Melinta Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Melinta Therapeutics
Compare insights from companies similar to Melinta Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Melinta Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Melinta Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Melinta Therapeutics.
Melinta Therapeutics financials insights
Gather financial insights about Melinta Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Debt
$30M
Melinta Therapeutics Tech Stack
A closer look at the technologies used by Melinta Therapeutics
Most Recent Scoops
Open Position
Open Position
Open Position
Left Company
Executive Move
Executive Moves, Left Company
Left Company
Executive Move
Executive Moves, Left Company
Melinta Therapeutics News & Media
CorMedix to acquire Melinta Therapeutics, Creating Diversified Specialty Company With Strong Presence in Acute Care Settings
BERKELEY HEIGHTS, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (“CorMedix”) (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, and Melinta Therapeutics LLC (“Melinta”), a private commercial-stage company providing innovative therapies for acute and life-threatening illnesses, today announced a definitive agreement for CorMedix to acquire Melinta. The selling shareholders will receive $3Melinta Joins NHIA Future of Infusion Advisory Council
ALEXANDRIA, Va. & PARSIPPANY, N.J.--(BUSINESS WIRE)--The National Home Infusion Association (NHIA) and Melinta Therapeutics, LLC (Melinta), a commercial-stage company providing innovative therapies for acute and life-threatening illnesses, are pleased to announce the addition of Melinta to NHIA’s Future of Infusion Advisory Council (FIAC). FIAC is a strategic advisory group comprised of manufacturing and service companies that are intensely invested in the home and alternate site infusion indusMelinta Therapeutics Announces IDWeek 2024 Presentations Focused on Melinta’s Portfolio of Commercial and Investigational Stage Products
PARSIPPANY, N.J.--(BUSINESS WIRE)--Melinta Therapeutics, LLC (Melinta), a commercial-stage company providing innovative therapies for acute and life-threatening illnesses, announced today, ten scientific presentations with data focused on Melinta’s portfolio of commercial and investigational stage products to be shared at Infectious Disease Week (IDWeek) 2024, Oct. 16-19, 2024, in Los Angeles, California. IDWeek is the combined annual meeting of the Infectious Diseases Society of America (IDSA)Melinta Therapeutics appoints senior Indian-origin exec as Chief Technology Officer
Melinta Therapeutics, a commercial-stage company in New Jersey providing innovative therapies for acute and life-threatening illnesses, has announced the appointment of an Indian-origin senior executive as its Chief Technology Officer.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Melinta Therapeutics
Sign Up For FreeTo access detailed company insights
Founded in 2000, Melinta Therapeutics biopharmaceutical firm that focuses on the design and development of novel broad-spectrum antibiotics for the treatment of antibiotic-resistant infections in hospital and community settings.... Read More
